ClinicalTrials.govpublic full text
Treatment of B-CLL With Autologous IL2 and CD40 Ligand-Expressing Tumor Cells + Lenalidomide
b-cell chronic lymphocytic leukemia, b-cll, vaccine, lenalidomide, ctl, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 877742
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.